Brokers’picks: Biocon, JP Power

Morgan Stanley upgrades Biocon

TARGET: Rs 392

CURRENT PRICE: Rs 309.85

Morgan Stanley says improved base business fundamentals should help deliver growth

It also cites progress in the bio-similar platform

Biocon has made progress in Phase III clinical trials for human insulin

Biocon will depend less on slow-growth statins

Citi maintains Buy on JP Power

TARGET: Rs 26

CURRENT PRICE: Rs 14.95

Citigroup maintains Buy, given the stock offers deep value with a high risk–high reward

Following the floods in Uttarakhand (leading to shutdown of 400MW Vishnuprayag project) the JP Power stock price has corrected sharply

To spend Rs530 cr on a cement grinding unit